Background: Current human influenza vaccines lack the adaptability to match the mutational rate of the virus and therefore require annual revisions. Because of extensive manufacturing times and the possibility that antigenic alterations occur during viral vaccine strain production, an inherent risk exists for antigenic mismatch between the new influenza vaccine and circulating viruses. Targeting more conserved antigens such as nucleoprotein (NP) could provide a more sustainable vaccination strategy by inducing long term and heterosubtypic protection against influenza. We previously demonstrated that intranodal mRNA injection can induce potent antigen-specific T-cell responses. In this study, we investigated whether intranodal administration...
Universal influenza vaccines should protect against continuously evolving and newly emerging influen...
Vaccination is one of the major strategies available for combating viral infections in humans. The s...
Influenza viruses are respiratory pathogens of public health concern worldwide with up to 650,000 de...
Background: Current human influenza vaccines lack the adaptability to match the mutational rate of t...
<div><p>Current hemagglutinin (HA)-based seasonal influenza vaccines induce vaccine strain-specific ...
AbstractVaccination is at present the most efficient way of preventing influenza infections. Current...
Influenza virus is a prominent cause of respiratory illness in humans. Current influenza vaccines of...
Due to antigenic drift of influenza viruses, seasonal influenza vaccines need to be updated annually...
International audienceTissue-resident memory (TRM) CD8+ T-cells play a crucial role in the protectio...
Since conserved viral proteins of influenza virus, such as nucleoprotein (NP) and matrix 1 protein, ...
Humans are exposed to influenza virus through periodic infections. Due to these repeated exposures, ...
Licensed seasonal influenza vaccines induce antibody (Ab) responses against influenza hemagglutinin ...
Nucleoside-modified, lipid nanoparticle-encapsulated mRNAs have recently emerged as suitable vaccine...
AbstractVaccination is the most effective method for the prevention of influenza virus infection. Cu...
Human influenza A viruses (IAVs) cause global pandemics and epidemics, which remains a nonignorable ...
Universal influenza vaccines should protect against continuously evolving and newly emerging influen...
Vaccination is one of the major strategies available for combating viral infections in humans. The s...
Influenza viruses are respiratory pathogens of public health concern worldwide with up to 650,000 de...
Background: Current human influenza vaccines lack the adaptability to match the mutational rate of t...
<div><p>Current hemagglutinin (HA)-based seasonal influenza vaccines induce vaccine strain-specific ...
AbstractVaccination is at present the most efficient way of preventing influenza infections. Current...
Influenza virus is a prominent cause of respiratory illness in humans. Current influenza vaccines of...
Due to antigenic drift of influenza viruses, seasonal influenza vaccines need to be updated annually...
International audienceTissue-resident memory (TRM) CD8+ T-cells play a crucial role in the protectio...
Since conserved viral proteins of influenza virus, such as nucleoprotein (NP) and matrix 1 protein, ...
Humans are exposed to influenza virus through periodic infections. Due to these repeated exposures, ...
Licensed seasonal influenza vaccines induce antibody (Ab) responses against influenza hemagglutinin ...
Nucleoside-modified, lipid nanoparticle-encapsulated mRNAs have recently emerged as suitable vaccine...
AbstractVaccination is the most effective method for the prevention of influenza virus infection. Cu...
Human influenza A viruses (IAVs) cause global pandemics and epidemics, which remains a nonignorable ...
Universal influenza vaccines should protect against continuously evolving and newly emerging influen...
Vaccination is one of the major strategies available for combating viral infections in humans. The s...
Influenza viruses are respiratory pathogens of public health concern worldwide with up to 650,000 de...